Clinical trial

Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis

NCT00395941 · Post Graduate Institute of Medical Education and Research, Chandigarh, Other · Completed

Key facts

NCT number NCT00395941
Title Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With Psoriasis
Lead sponsor Post Graduate Institute of Medical Education and Research, Chandigarh, Other
Status Completed
Phase Phase 2
Study type Interventional
Conditions Psoriasis
Intervention type Drug
Interventions Pioglitazone, Acitretin
Enrollment 40
Start date Dec 1, 2006
Primary completion Dec 1, 2008
Completion Dec 1, 2008
First posted Nov 6, 2006
Last update posted Mar 20, 2019
Countries India

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies